ARCHIVES

In Brief: CREG To Be Used In Viral Oncology, Nutrition, Cell Kinetics, Immunology, Rauscher Tells NCAB

This article is from The Cancer Letter archive.

Vol. 01 No. 14 | April 4, 1975

Download PDF Visit The Full Archive

Related Articles

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

March 1, 2002

In Brief: Allegheny Wins NSABP Recompetition; Luri Cancer Center Hosts Princess Diana

June 14, 1996

In Brief: Columbia’s Marks Reportedly Will Move To MSK; FDA Committee to Consider THC For Group C List

May 23, 1980

In Brief: Whittaker Corp, Trying To Hire NCI Director; Environmental Carcinogenesis On NCAB Agenda

February 13, 1976

New Toxicology Protocol Works, Predicts Safe starting Doses, Saves $1 Million

June 25, 1982

Chabner : Opportunity To Set Own Agenda Reason For Leaving

October 28, 1994